GMAB – genmab a/s - american depositary shares (US:NASDAQ)

News

Major Shareholder Announcement
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2026
Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S®) in Combination with Bevacizumab in Advanced Ovarian Cancer
Genmab: Multiple Binaries Could Alter The Thesis [Seeking Alpha]
Major Shareholder Announcement
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com